Haematology Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2017

  • ID: 4342762
  • Report
  • 131 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • BioMedomics Inc
  • Cascade Metrix, Inc.
  • Emosis SAS
  • genedrive plc
  • KeenCAT Technologies
  • PortaScience Inc
  • MORE
Haematology Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Haematology Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2017" provides an overview of Haematology Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Haematology Rapid Tests & Point of Care (POC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Haematology Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Haematology Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Haematology Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • BioMedomics Inc
  • Cascade Metrix, Inc.
  • Emosis SAS
  • genedrive plc
  • KeenCAT Technologies
  • PortaScience Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 Haematology Rapid Tests & Point of Care (POC) Overview
3 Products under Development
3.1 Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
3.2 Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
3.3 Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
3.4 Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
3.5 Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
4 Haematology Rapid Tests & Point of Care (POC) - Pipeline Products under Development by Companies
4.1 Haematology Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
4.2 Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
5 Haematology Rapid Tests & Point of Care (POC) Companies and Product Overview
5.1 Atomo Diagnostics Pty Limited Company Overview
5.1.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
5.2 BioMedomics Inc Company Overview
5.2.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Biosurfit, SA Company Overview
5.3.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
5.4 Carclo Diagnostic Solutions Ltd Company Overview
5.4.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cascade Metrix, Inc. Company Overview
5.5.1 Cascade Metrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Correlia Biosystems, Inc. Company Overview
5.6.1 Correlia Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.7 EKF Diagnostics Holdings Plc Company Overview
5.7.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Emosis SAS Company Overview
5.8.1 Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
5.9 ET Healthcare, Inc. Company Overview
5.9.1 ET Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.10 genedrive plc Company Overview
5.10.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Helena Laboratories Corp. Company Overview
5.11.1 Helena Laboratories Corp. Pipeline Products & Ongoing Clinical Trials Overview
5.12 KeenCAT Technologies Company Overview
5.12.1 KeenCAT Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.13 Ohio State University Company Overview
5.13.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
5.14 PortaScience Inc Company Overview
5.14.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Sanguina LLC Company Overview
5.15.1 Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview
5.16 Siemens Healthcare GmbH Company Overview
5.16.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.17 T2 Biosystems Inc Company Overview
5.17.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 The University of Melbourne Company Overview
5.18.1 The University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview
5.19 Universal Biosensors Inc Company Overview
5.19.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Haematology Rapid Tests & Point of Care (POC)- Recent Developments
6.1 Jun 15, 2017: Consort Medical: Full year results
6.2 Jun 14, 2017: Alere Reports First Quarter 2017 Financial Results
6.3 Jun 05, 2017: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results
6.4 May 22, 2017: Alere Provides Preliminary Unaudited Financial Results
6.5 May 19, 2017: Henry Ford Health System to Present Webinar on T2MR
6.6 May 17, 2017: FDA warns Americans about risk of inaccurate results from certain lead tests
6.7 May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings
6.8 May 04, 2017: Lea Paloheimo appointed Biohit Oyj’s R&D and production director
6.9 May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results
6.10 Apr 27, 2017: Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2017 and Declares Quarterly Cash Dividend
6.11 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results
6.12 Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016
6.13 Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016
6.14 Apr 10, 2017: Akers Biosciences to Commercialize Heparin PF4 Rapid Test in Puerto Rico
6.15 Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016
6.16 Mar 29, 2017: Sysmex America Announces Leadership Promotions
6.17 Mar 28, 2017: EMOSIS Announces the Opening of a Subsidiary in Israel
6.18 Mar 27, 2017: EMOSIS announces the appointment of Nicolas Rufin as Head of marketing and sales
6.19 Mar 26, 2017: Emosis Announces The Appointment Of Aurore Andre As Emosis CEO
6.20 Mar 20, 2017: EKF Diagnostics Holdings: Final results
6.21 Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors
6.22 Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day
6.23 Mar 09, 2017: Alere Provides Update on Arriva Medical
6.24 Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results
6.25 Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results
6.26 Feb 20, 2017: Biohit Group Financial Statement Release 2016
6.27 Feb 20, 2017: Sysmex America to Distribute Erythrocyte Sedimentation Rate Products from Alifax
6.28 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results
6.29 Feb 01, 2017: Akers Biosciences Announces Trading Update For The Twelve Months Ended December 31, 2016
6.30 Jan 26, 2017: Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2017, Declares Quarterly Cash Dividend
6.31 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories
6.32 Jan 10, 2017: Abaxis Reports Preliminary Financial Performance For The Third Quarter Of Fiscal 2017
6.33 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016
6.34 Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation
6.35 Jan 04, 2017: Alere Provides Update on Arriva Medical
6.36 Dec 28, 2016: Alere Provides Update on Arriva Medical
6.37 Dec 19, 2016: Akers Biosciences Announces 3-year Agreement with Greater New York Hospital Association for PIFA Heparin/Platelet Factor-4 Rapid Assay
6.38 Dec 19, 2016: Akers Biosciences Announces 3-year Agreement with Greater New York Hospital Association for PIFA PLUSS PF4 Rapid Assay
6.39 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe
6.40 Dec 14, 2016: Siemens Healthineers to significantly expand its Walpole, Mass. Laboratory Diagnostic manufacturing facility
6.41 Dec 14, 2016: Consort Medical: Directorate Change
6.42 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm
6.43 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition
6.44 Dec 06, 2016: Consort Medical Reports Interim Results For The Six Months Ended 31 October 2016
6.45 Nov 25, 2016: Consort Medical: CFO Appointment
6.46 Nov 14, 2016: Akers Biosciences Announces Q3 Earnings
6.47 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results
6.48 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent
6.49 Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results
6.50 Oct 25, 2016: Abaxis Reports Financial Performance For The Second Quarter Of Fiscal 2017
6.51 Oct 24, 2016: Study links small RNA molecule to pregnancy complication
6.52 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report
6.53 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results
6.54 Sep 01, 2016: Blood test for new breast cancer subtype delays its progression
6.55 Aug 26, 2016: Ilari Patrakka appointed Biohit Oyj’s Sales and Marketing Director
6.56 Aug 25, 2016: Alere Recalls INRatio and INRatio2 PT/INR Monitoring System Due to Incorrect Test Results
6.57 Aug 18, 2016: Frank Witney Joins RareCyte Board of Directors
6.58 Aug 18, 2016: Biohit Group Half Year Financial report 2016
6.59 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results
6.60 Aug 17, 2016: Consort Medical Announces Directorate Change
6.61 Aug 11, 2016: Akers Biosciences Announces H1 and Q2 2016 Earnings
6.62 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
6.63 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Table 2: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
Table 3: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
Table 4: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
Table 5: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
Table 6: Haematology Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
Table 7: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Table 8: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AtomoRapid - Coagulation Monitoring - Product Status
Table 10: AtomoRapid - Coagulation Monitoring - Product Description
Table 11: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Sickle SCAN - Product Status
Table 13: Sickle SCAN - Product Description
Table 14: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Spinit Device - Blood Quantitation Anemia Assay - Product Status
Table 16: Spinit Device - Blood Quantitation Anemia Assay - Product Description
Table 17: Spinit Device - Thrombocytopenia Assay - Product Status
Table 18: Spinit Device - Thrombocytopenia Assay - Product Description
Table 19: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Micropoc-CAT - Haemostasis Assay - Product Status
Table 21: Micropoc-CAT - Haemostasis Assay - Product Description
Table 22: Cascade Metrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Multiple Blood Analytes Test - Product Status
Table 24: Multiple Blood Analytes Test - Product Description
Table 25: Correlia Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Electrokinetic Lateral Flow Test - Product Status
Table 27: Electrokinetic Lateral Flow Test - Product Description
Table 28: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Point-Of-Care Test - Coagulation - Product Status
Table 30: Point-Of-Care Test - Coagulation - Product Description
Table 31: Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Diagnostic Test Kit - Heparin-Induced Thrombocytopenia - Product Status
Table 33: Diagnostic Test Kit - Heparin-Induced Thrombocytopenia - Product Description
Table 34: ET Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Pylon Assay - D-Dimer - Product Status
Table 36: Pylon Assay - D-Dimer - Product Description
Table 37: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Genedrive - Factor V Leiden - Product Status
Table 39: Genedrive - Factor V Leiden - Product Description
Table 40: Helena Laboratories Corp. Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Cascade Abrazo - APTT - Product Status
Table 42: Cascade Abrazo - APTT - Product Description
Table 43: Cascade Abrazo - c-ACT - Product Status
Table 44: Cascade Abrazo - c-ACT - Product Description
Table 45: Cascade Abrazo - c-ACT-LR - Product Status
Table 46: Cascade Abrazo - c-ACT-LR - Product Description
Table 47: Cascade Abrazo - Direct Thrombin Inhibitors - Product Status
Table 48: Cascade Abrazo - Direct Thrombin Inhibitors - Product Description
Table 49: Cascade Abrazo - Fibrinogen - Product Status
Table 50: Cascade Abrazo - Fibrinogen - Product Description
Table 51: Cascade Abrazo - Heparin Titration - Product Status
Table 52: Cascade Abrazo - Heparin Titration - Product Description
Table 53: Cascade Abrazo - LMWH - Product Status
Table 54: Cascade Abrazo - LMWH - Product Description
Table 55: Cascade Abrazo - Protamine Titration - Product Status
Table 56: Cascade Abrazo - Protamine Titration - Product Description
Table 57: Cascade Abrazo - PT-C - Product Status
Table 58: Cascade Abrazo - PT-C - Product Description
Table 59: KeenCAT Technologies Pipeline Products & Ongoing Clinical Trials Overview
Table 60: HematoCAT - Product Status
Table 61: HematoCAT - Product Description
Table 62: Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Diagnostic Assay - Thrombotic Thrombocytopenic Purpura - Product Status
Table 64: Diagnostic Assay - Thrombotic Thrombocytopenic Purpura - Product Description
Table 65: PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 66: PortaWBC - Product Status
Table 67: PortaWBC - Product Description
Table 68: Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 69: AnemoCheck - Product Status
Table 70: AnemoCheck - Product Description
Table 71: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Advia 120 Hematology System - IRF Test - Product Status
Table 73: Advia 120 Hematology System - IRF Test - Product Description
Table 74: Advia 120 Hematology System - MPC Test - Product Status
Table 75: Advia 120 Hematology System - MPC Test - Product Description
Table 76: Advia 120 Hematology System - MPM Test - Product Status
Table 77: Advia 120 Hematology System - MPM Test - Product Description
Table 78: Advia 2120 Hematology System - MPC Test - Product Status
Table 79: Advia 2120 Hematology System - MPC Test - Product Description
Table 80: Advia 2120 Hematology System - MPM Test - Product Status
Table 81: Advia 2120 Hematology System - MPM Test - Product Description
Table 82: Advia 2120i Hematology System - MPC Test - Product Status
Table 83: Advia 2120i Hematology System - MPC Test - Product Description
Table 84: Advia 2120i Hematology System - MPM Test - Product Status
Table 85: Advia 2120i Hematology System - MPM Test - Product Description
Table 86: T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 87: T2HemoStat - Product Status
Table 88: T2HemoStat - Product Description
Table 89: T2MR Assay - Platelet Function Testing - Product Status
Table 90: T2MR Assay - Platelet Function Testing - Product Description
Table 91: The University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Thrombin Generation Assay - Product Status
Table 93: Thrombin Generation Assay - Product Description
Table 94: Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Diagnostic Assay - Coagulation - Product Status
Table 96: Diagnostic Assay - Coagulation - Product Description
Table 97: Glossary

List of Figures
Figure 1: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Figure 2: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
Figure 3: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
Figure 4: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
Figure 5: Haematology Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Atomo Diagnostics Pty Limited
  • BioMedomics Inc
  • Biosurfit, SA
  • Carclo Diagnostic Solutions Ltd
  • Cascade Metrix, Inc.
  • Correlia Biosystems, Inc.
  • EKF Diagnostics Holdings Plc
  • Emosis SAS
  • ET Healthcare, Inc.
  • genedrive plc
  • Helena Laboratories Corp.
  • KeenCAT Technologies
  • Ohio State University
  • PortaScience Inc
  • Sanguina LLC
  • Siemens Healthcare GmbH
  • T2 Biosystems Inc
  • The University of Melbourne
  • Universal Biosensors Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll